Biocom published its 2026 Economic Impact Report covering California’s life science companies.
Public source
Publisher name
Public post
Jonathan Norris, managing director at HSBC Innovation Banking and a contributor to Biocom’s 2026 Economic Impact Report, has spent decades tracking how capital moves thr…
Company
Biocom
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 201–500 employees
About Biocom
For over 30 years, Biocom has advanced the life science industry with transformative resources that accelerate innovation. We help companies build meaningful connections and gain valuable insights through Conferences & Events, deliver access to Funding & Partnering opportunities, provide Group Purchasing solutions that drive efficiency and savings, champion Policy & Advocacy that protects and advances the innovation ecosystem, and strengthen talent pipelines through Workforce Development. Biocom is how the life science industry gets connected.
See moreLatest activity
Latest activity from Biocom
13 signals
Products & Services
Biocom launched the Innovation Readiness Index, a diagnostic designed to help life science organizations benchmark their capabilities, identify gaps, and compare with peers.
Products & Services
Biocom launched ILLUMINATE, a pivotal Phase 2 trial evaluating an autologous CAR T cell therapy for children and young adults with newly diagnosed Diffuse Intrinsic Pontine Glioma (DIPG).
Capital & Finance
Biocom member BrainChild Bio raised $116M Series A funding.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
MassBio
MassBio reports that in 2025, Massachusetts companies out-licensed $10.9 billion across 27 deals.
Research & Knowledge
BioM Biotech Cluster Development GmbH
BioM Biotech Cluster Development GmbH published the 2025/26 Biotech Report titled BIOTECH IN BAVARIA - WHERE CHAMPIONS GROW.
Research & Knowledge
BioCentury Inc.
BioCentury Inc. published its annual Pharma Deal Analysis finding that deals by 21 top pharmaceuticals in the past 12 months are clustering in breakthrough new technologies.
Research & Knowledge
Biotechnology Innovation Organization
Biotechnology Innovation Organization commented on the FDA Expedited IND Pilot Program, backing its rolling review concept.
Research & Knowledge
Kiin Bio